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Abstract  
Purpose: This qualitative study was concerned with investigating community pharmacists’ thoughts on the use of two brief scales to 
measure patient outcomes and therapeutic alliance in the context of their Medication Therapy Management (MTM) services. The 
scales were originally developed for use in behavioral healthcare, but were used in a novel (community pharmacy) setting as part of a 
previous parent study. We describe this practice (using these scales in a novel setting) as an innovative practice, report on the 
pharmacists’ experiences with the practice, and discuss relative advantages and disadvantages for integrating the use of the scales 
as part of routine practice. 
Methods: Six community pharmacy practitioners participated in a semi-structured interview pertaining to the use of the scales in 
their MTM services. Pharmacist interviews were transcribed, analyzed according to qualitative content analysis methodology, and 
presented in relation to the guiding interview questions.  
Results: Pharmacists had varying opinions on the use of the scales as part of their practice. Initial concerns included patient 
(mis)understanding about the purpose and proper completion of the scales, as well as apprehension about the use of the 
information. These concerns were largely resolved through education, repeated use, and routinization. Pharmacists, in general, saw a 
value to using these scales in clinical practice, for clinical and professional reasons, although there was variability on the degree to 
which pharmacists integrated the scales into practice after the study completion. Pharmacists had varied opinions as well as on the 
degree to which the use of the scales would impact medication adherence. Pharmacists were most surprised by how much 
participation in this study prompted them to reflect on their interactions with patients.  
Conclusions: Pharmacists, in general, were receptive to participating in the parent study and using two brief scales to measure 
patient outcomes and therapeutic alliance. Pharmacists had varying opinions on the degree to which the use of these scales could 
impact patient medication adherence, although they perceived other value and benefits secondary to the interactions. While most 
pharmacists did not maintain formal use of the scales after study end, they took away general principles of patient-centered care and 
individualized feedback. 
 
 
Introduction 
Adherence is the extent to which a patient’s behavior 
coincides with medical or prescribed health advice.
1
 Patient 
medication adherence, or taking medications as prescribed, is 
considered to be a significant clinical issue.
2
 The Study of 
Medication Adherence and the Therapeutic Alliance 
(SMARTA), an industry-sponsored study conducted by 
University of Pittsburgh School of Pharmacy, was a project 
intended to assess the relationship between the 
administration of two scales and medication adherence. In 
SMARTA, six pharmacists in a community pharmacy chain  
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administered two brief scales originally developed for use in 
psychotherapy (the Outcome Rating Scale and the Session  
Rating Scale, or ORS and SRS, respectively)
3,4
 to patients 
presenting for Medication Therapy Management (MTM) 
services. Two hundred and one participants were enrolled in 
an initial session, and approximately 34% of participants 
received up to three MTM sessions where the scales were 
utilized. Results suggested that administration of the ORS and 
SRS in this context had a positive impact on patient 
medication adherence.
5 
 
The purpose of this qualitative study, a secondary study of 
SMARTA, was to interview participating pharmacists in order 
to evaluate their thoughts about the use of the scales (which 
were a chief SMARTA procedure). As noted, the ORS and SRS 
were originally developed for use in behavioral healthcare 
and have not been used, to our knowledge, in a community 
Original Research PHARMACY PRACTICE 
 
http://z.umn.edu/INNOVATIONS                              2011, Vol. 2, No. 2, Article 43                   INNOVATIONS in pharmacy   2 
 
pharmacy setting.  Given the innovative nature of using these 
instruments in this clinical setting, we interviewed the 
participating pharmacists to understand how the use of the 
scales affected their clinical practice (if at all) and might be 
adopted and integrated as part of routine practice. 
 
 
Before describing the qualitative study methods, results, and 
conclusions, we felt it would be helpful first to describe the 
instruments themselves and, second, ground the reader in 
the everyday application of the instruments the SMARTA 
pharmacists used in the project. Although some technical 
study procedures were involved in the “day-to-day” work 
(such as providing information to participants about informed 
consent), we will describe only the administration procedures 
after a participant (a pharmacist’s patient) was enrolled in the 
project.  
 
The SMARTA project 
The ORS and SRS are two brief, four-question scales intended 
to measure participant self-report of general well-being 
outcomes and perception of the therapeutic alliance, 
respectively. The outcome constructs for the ORS are 
“Individual,” “Interpersonal,” “Social,” and “Overall.” The SRS 
constructs are “Relationship,” Goals and Topics,” Approach or 
Method”
1
 and “Overall.”  The specific scale questions are 
presented in Table 1. 
 
Table 1: ORS and SRS Questions 
 
ORS SRS 
How have you been doing 
personally? 
To what degree did you feel 
heard and understood 
today? 
How have things been going 
in your relationships? 
To what degree did we work 
on the issues that you 
wanted to work on today? 
How have things been going 
for you socially? 
How well did my approach, 
the way I worked, make 
sense and fit for you? 
How would you rate how 
things in your life are going 
overall? 
How would you rate how 
things were in today’s 
session overall? 
 
                                                 
1
 We slightly modified the Approach question on the SRS to 
reflect the clinical context of community pharmacy rather 
than behavioral health; thus, the Approach question was 
reworded to refer to a “pharmacist’s” approach rather than a 
“therapist’s” approach. 
Pharmacists could avail themselves to two administration 
types for either or both instruments: written or oral (oral 
versions are presented above). For the written version, 
participants could complete a visual analog scale, where 
“negatively phrased” statements presented on the left and 
“positively phrased” statement presented on the right are 
separated by a 10 cm line. Participants read both the left and 
right hand statements and mark their scores with hash marks 
along the 10 cm continuum for each of the four questions. 
There are no numbers on the continuum; in order to score 
the instrument, the pharmacist uses a standard ruler to 
measure the hash mark to the nearest centimeter and notes 
the score (1cm=1, 2cm=2, etc.). For the oral version, 
pharmacists simply read the statements to the participants 
and participants provide oral responses on a scale from 1-10 
(where 1 is worst and 10 is best). Each instrument has a total 
score of 40, each with a significant clinical indicator described 
below. Prior to implementation, pharmacists received a one 
hour phone training/webinar on the theory, administration, 
and interpretation scales. 
 
For study purposes, pharmacists were to administer the most 
appropriate version (written or oral) of the ORS at the 
beginning of an MTM session, and the most appropriate 
version of the SRS at the end of an MTM session (in this 
context, an MTM session was defined as an interaction where 
pharmacist and patient had the opportunity to communicate, 
for example, during a comprehensive medication review).  
For the ORS, pharmacists were to score the instruments “in 
the moment” and use the scores to guide to the MTM 
session. The ORS has a cutoff point of 25, meaning that any 
total scale score below 25 is a prompt for the provider to 
develop a discussion with the participant. For example, a 
participant may have rated three of the four ORS items with 
“7s” but rated the fourth item a “2,” for an ORS scale score of 
23. The pharmacist would then first invite the participant into 
a discussion, and, if the participant agreed, would inquire into 
the significance of that low score. (Specific instances of these 
interactions will be described in detail in the Results and 
Discussion sections). For the SRS, pharmacists could 
administer, score, and provide feedback on the scores within 
the last few moments of the MTM session, or score the 
instrument after the session and utilize the information 
during the subsequent session (if any). The SRS has a 
relatively higher cutoff point of 36, meaning that any score 
lower than 36 is also a prompt for the pharmacist to initiate 
discussion. For example, a participant may rate the 
pharmacist/session as “10” in three of the four items, but 
then provide a rating of “5” in the fourth item, for a total 
scale score of 35. The score would compel the pharmacist to 
solicit the participant’s feedback on how to improve that 
score on that item for the next session.  
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Methods 
The sample for this study was purposive and included the six 
community pharmacists who participated in SMARTA. The 
data collection method was a single-session, semi-structured 
interview, conducted by the principal author (M. Melczak) via 
telephone and tape-recorded. The interviews took place 
approximately 60 days after the end of SMARTA. Pharmacists 
were interviewed separately, not as part of a focus group. 
Pharmacists were provided with the semi-structured 
interview questions beforehand to prepare for the interview. 
The study was approved by the University of Pittsburgh IRB.  
Before actively participating in the interview, pharmacists 
were provided with an informational script satisfying 
University IRB consent procedures. The script described the 
study design and research procedures, the voluntary nature 
of the study, and the recording procedures. Participants then 
gave verbal consent to participate in the study. Even though 
the sample size was small, identifying information was 
redacted from any transcription, and confidentiality was 
stressed. Pharmacists were compensated for their 
participation in the interviews, which lasted approximately 30 
minutes on average (range 15-35 minutes). 
 
The questions for the semi-structured interview were based 
on key concepts from diffusion of innovation theory
6 
and 
suggestions from the developer of the ORS and SRS.
7
 The 
questions included: 
1. Did you have concerns about using these instruments in 
your practice?  If yes, what were those concerns? Do 
those concerns still exist? If yes, please describe how 
they continue. If no, please describe how your concerns 
were resolved. Do you have any new concerns? 
2. How did the patients respond to the instruments when 
you first applied them?  How do they respond now? 
3. Describe the degree of integration of these instruments 
into your routine practice at this time, including any 
facilitators or barriers to integration. 
4. Describe the potential value, if any, for integrating these 
instruments as part of routine MTM service. 
5. An original goal of this study was to assess patients’ 
responses to the ORS/SRS 
questions and their medication adherence. As a 
pharmacist, what are your thoughts about the use of 
these tools and medication adherence? That is, do you 
think medication adherence is improved through the use 
of these tools, is made worse, or is not affected in either 
direction? 
6. Was your work affected by using these instruments? If 
so, what difference has emerged? How do you think your 
patients/clients are different, if at all? 
7. What surprised you the most? 
While these questions appear to be fixed and finite, 
pharmacist responses often led to new questions or different 
ideas. Data were analyzed in terms of the guiding questions 
or interview-generated ideas through the use of a qualitative 
content analysis methodology. 
 
Qualitative data can be analyzed in numerous ways. With 
qualitative content methods, data analysis can follow a 
systematic procedure.
8,9  
First, the original recorded 
communication was transcribed as closely to verbatim as 
possible, including both interviewee and interviewer 
statements. Then, each response, ending at each question, 
was reviewed to get an overall impression of the response. 
Participant responses were then approached as “meaning 
units”
10
 in relation to the guiding interview question. 
Statements were then evaluated in terms of their degree of 
fit with the guiding question and presented as evidentiary 
extensions of the question domains. For example, one 
overarching domain of Question 1 was “concerns.” 
Respondent statements that provided evidentiary support of 
these domains were included in results. Statements that did 
not support that domain were not included or included in 
other domains. Thus, the purpose of this methodology was 
not to derive a conceptual domain, but to evaluate 
statements with a degree of fit to those so given as guiding 
questions. 
 
Results 
Six pharmacists were interviewed (five female and one male). 
We did not ask for other demographic information. During 
transcription, one of the interviews was lost due to a 
technical malfunction; the pharmacist was not re-
interviewed. The following results are from five pharmacist 
interviews. Pharmacist quotes are notated by a respective 
code (P1, P2, etc.). 
 
Question 1: Concerns 
Pharmacists had concerns about the use of the scales for a 
number of reasons. First, pharmacists had concerns about 
patients- and perhaps themselves- being able to understand 
the administration of the instruments. 
P1: I knew that approximately 30% of the population 
was illiterate in some form or another… 
P3: ...but on the first one where you have the line, I 
had a lot of problems just wanting to write on the 
line how they felt, so it was very hard to explain what 
the first line was…I just think the first line was 
confusing for a lot of the patients….Maybe it was just 
me. 
P5: …the biggest concern was and somewhat still 
exists in that, um, the education level of the 
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patients…some of my patients have a hard time 
relating a number to how they’re feeling. 
 
One pharmacist also had concerns about the amount of time 
it would take to administer the instrument: 
P1: … the patient interaction would take a 
considerable amount of time. 
 
And, accordingly, there was a concern if the time cost would 
yield a benefit. 
P1: … it was important to me and the rest of my 
team that we be able to make this worth our time. 
 
One pharmacist had a concern about the “authenticity” of 
the encounter. 
P2: …First of all, my concern, initially, was, “How was 
I going to administer these scales and not make it 
seem like I just wanted some feedback?”  
 
There also appeared to be anticipatory anxiety about asking 
“personal questions” of the patients, and how the patients 
might respond to these questions: 
P2: …oh my goodness, how am I going to get them to 
participate…(the patient might think) ‘I don’t even 
want to think about that’…. 
P4: …I think it was a little more personal than some 
people I thought might be willing to discuss 
 
Question 1: Resolutions 
Pharmacists provided various resolutions to their concerns, 
including the alternative instrument administration (i.e., 
reading the questions to patients instead of patients filling 
out the scales themselves), breaking the “awkwardness” 
barrier, generating revenue (at least for the purposes of the 
study), “just doing it”, and proposing instrument redesign. 
P1: Number one, my fears were resolved about the 
illiteracy problem, because you gave a script to be 
able to allow the patients, be able to read to 
them…and then as far revenue generating or making 
this worth our time, um, I think that it certainly was. 
After we got into and got going…I did not feel the 
interaction took longer, maybe about 5 or 10 
minutes longer than it normally would. 
P2. I think once I got it into a routine, once I felt 
comfortable, once they felt comfortable with it, I 
think it was not a problem. 
P4: My concerns were resolved by just doing it 
basically.  
P5: I think maybe pictures would be really good for 
some people, you know like the pain scale with 
smiley faces… 
 
 
Question 2: Patient Responses To Instruments Upon First 
Application 
Pharmacists noted that patients responded differently to 
both the instrument administration as well as the content of 
the instruments. In some cases, the actual patient response 
was commensurate with the pharmacists’ concerns. With 
regard to the former: 
P1: Some were shocked…When I would put the piece 
of paper in front of them they were like, 
“What…what am I supposed to do?” …it was a little 
bit difficult to comprehend, so I had to explain it 
probably to almost every single patient… 
P2: A lot of them didn’t understand it… 
P3: …for the most part they were OK with it. They 
were like, “What is this pharmacist giving me this 
for?”…but you know generally they responded well. 
P5: When I first applied it, the patients were kind of 
apprehensive… (based on my patients’ background) I 
think the apprehension was “are you going to sell my 
information or have my name listed on anything?” 
 
With regard to the latter, pharmacists reported that some 
patients responded emotionally, which in turn reflected 
pharmacists’ concerns about lack of training and patient 
unpredictability. 
P1: I  had one patient that we ended up opening a 
Pandora’s Box… sometimes you get information you 
didn’t expect or you didn’t realize you were going to 
get and you don’t know how to handle because you 
haven’t been trained. I ended up putting a tissue box 
in my consultation area because more times than not 
patients did end up crying during our sessions.  
P4: I mean, some people get kind of emotional about 
it and when you kinda opened the can of worms you 
didn’t know what was there… 
 
Question 2: Patient Responses After Additional Applications 
Pharmacists reported that while some patients refused to do 
additional surveys, most said that administering the scales 
became easier, awkwardness melted away, and some 
patients perceived a value in the service. 
P1: …Once they filled it out, they had no problems 
doing it. 
P2: Um, no, no. I think once I got it into a routine, 
once I felt comfortable, once they felt comfortable 
with it, I think it was not a problem 
P3: …For the most part they were OK with 
it….They’ve gotten more used to it as I call them and 
you know do their second session, their third session, 
and a lot of them have really opened up a good 
opportunity to improve on the relationship that we 
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probably wouldn’t have had without the follow-up 
so, it was a good tool for sure, especially it seemed 
like you could really tell some things were really 
bothering people they may not have planned on 
talking about otherwise. So, but, um, all in all, I only 
had like two people tell me they didn’t want to 
participate, so… 
P4: …for the most part people are forthright and, um, 
comfortable responding and actually take it as 
something, um, as a good service. 
 
Question 3: Degree of Integration, Facilitators and Barriers 
After completion of the study, we do not believe pharmacists 
maintained actual use of the scales, but note that most have 
made modifications to their practice, or at least had a shift in 
clinical practice philosophy: that an emphasis on “care” over 
knowledge can foster better relationships. 
 
With regard to modification of the initial practice, one 
pharmacist derived a unique, abbreviated metric to evaluate 
individual “stress”: 
P1: I have taken this part of the study…and 
integrated it into my patient encounters at the 
clinic…I shortened it to one sentence and I give them 
numbers one through five. 
 
This pharmacist’s statement also demonstrates that while the 
philosophy underpinning the use of the scales is important, 
there are also perceived constraints in this process, such as 
limited time. Accordingly, while the original scales were also 
very brief and could be administered in a few minutes, 
further refining to one question suggests the pharmacist’s 
perceived time constraint.  
 
This same pharmacist also noted a “core element” in practice, 
which refers can be described a “vision” or ”mission 
statement”: 
P1: The core element that I truly believe will help 
establish a trust and bond with these patients, as 
well as increase their compliance is…”People don’t 
care how much you know until they know how much 
you care”. 
 
One pharmacist noted a shift to what is often termed 
“patient-centered” or patient-focused care:  
P3: It’s really helped me I guess be more personal 
and take away from my agenda and look more, you 
know, at what it is the patient really wants to get out 
of this… 
 
Another pharmacist did not maintain use of the scales, but 
saw a niche opportunity: 
P4: I actually have not used it outside of the study 
eligible patients, but I could see a niche, potentially, 
for it. 
 
The niche here is an investment in personal relationships, 
building relationships, and fostering trust that can impact 
adherence. Potential value is also addressed in the next 
section. 
 
A final pharmacist noted asking broad questions about 
personal well-being as an introduction before inquiring 
directly about medicines. The focus here appeared to have 
shifted from a medication management ethos to a health 
management ethos: 
P5: So I guess I open up with more general broad 
questions to see how they’re doing and not dive so 
much right into their medicines. 
 
Question 4: Potential Value 
Pharmacists, in general, did see potential value for the 
general line of questioning or interaction (although not 
necessarily the formal use of the scales). The value for the 
use of the scales included identifying medication issues that 
might otherwise have gone unknown and hence 
unaddressed, using specific feedback to improve services, and 
maintaining focus on patient needs. Feedback from patients 
also helped to improve services not simply in the moment 
with a particular patient, but across all patients, suggesting a 
ripple effect. 
P2: But it was interesting the feedback that I got, 
which was all positive: “But we were glad that you 
were here to help with this and with this,” so they 
gave me specific examples, which helped me better 
my MTM sessions with my other patients. So I knew 
exactly the things I need to make sure I am doing 
from asking the patient, so it kept me on focus. 
P3: …it spurred a lot of good conversation and I was 
able to identify things you might not necessarily 
would have identified… 
P4: (referring to the therapeutic alliance scale) I think 
it’s a good way to evaluate your performance as a 
health care profession and finding ways that you can 
improve on certain things and aspects. 
 
Question 5: Perceived Impact of the Intervention 
Pharmacists were asked to what degree they believed their 
intervention would have on patient medication adherence. 
Pharmacists had varying opinions, from beliefs in positive 
outcomes to uncertainty to skepticism. 
P1: I think it will positively impact compliance. 
P2: That’s still a question mark, because, based on 
the follow-ups, it seems like it’s helping, but I’m not 
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sure if it’s the fact that it was tools that were used, 
or the fact that we’re calling back checking in on 
them which we said we would do, call you and make 
sure things were ok…so the debate is still out on that 
in my book 
P4: I think potentially there is some benefit there… 
but I don’t know necessarily how you delineate the 
true cause of it… 
P5: I think that’s a difficult question for me to 
answer. 
 
A few pharmacists noted an “intervening variable” for 
medication adherence: trust. These pharmacists believed that 
creating a trusting relationship would make their 
recommendations easier to accept and to follow. 
P3. Um, I definitely think that it incorporates a level 
of trust in the pharmacist in our recommendations, 
so I think it would improve adherence. 
P5: I think it helps because I think it helps with that 
trusting relationship and then they’re more willing to 
listen to your recommendations and they actually 
see you as someone they can come to with other 
problems, not just “Hey I can’t get my medicine 
refilled”. 
 
Question 6. Impact on Work and Perception of Patients 
This question asked pharmacists how participating in the 
study impacted their perception of their own work and of 
their patients. One pharmacist noted that participation 
allowed her to reflect on her own professional values and 
refocus on her patients.  
P1: I was um very convinced this would be a positive 
impact on our patients, but had no idea how much it 
would impact myself as a provider. I think it has 
made me a better provider…. I had gotten into the 
rut where I wasn’t seeing the patient any more, 
honestly, and this study helped me realize that, um, 
I’m missing the most important part, which is the 
patient…. I’m starting to see that I’m developing a 
relationship more like I used to when I first got out of 
pharmacy school and was gung-ho about patient 
care. 
 
A second pharmacist suggested that understanding a 
patient’s personal life informed her clinical decision making, 
but more so contributed to seeing the patient as a person. 
P2: So it kinda changed my direction on how I 
handled patients, because you never know what 
their personal life is like… and then for me trying to 
assist them from a medical standpoint, it was just, I 
don’t know, kinda made me think about the things I 
recommended as far as a cost-wise, because many 
said money was a situation for them, it was hard for 
them to pay for medications, so therefore their 
quality of life was low…so it kinda changed my 
direction in how I look at my recommendations and 
things I say to my patients, which I’ve done all along, 
but this kinda opened my eyes to it because now I 
can actually see this person when I asked them about 
their quality of life… 
 
A third pharmacist noted that developing a “personal 
approach” was a perceived value to a patient who might not 
have otherwise presented for services. 
P3: “One lady came in with her husband and I went 
through the whole process. She wanted to come in 
for one after that…I don’t know if that would have 
happened without him participating because I think 
it was a more personal approach that appealed to 
her….Typically I don’t, I probably don’t have as much 
of a personal approach before I started doing this 
study, so I know it’s helped me a lot, too. 
 
Another pharmacist repeated a previously mentioned maxim, 
“They don’t care how much you know until they know how 
much you care.” This maxim constituted what appeared to be 
a mission statement for daily practice. There is also further 
evidence of the belief that a trusting and caring relationship 
can contribute to patient adherence, or at least promote the 
perception of better service. 
P4: Just show how much you care then they’ll start 
listening to you. I tried to be more diligent in using 
this as part of my own day to day practice…hopefully 
they’re getting better care, or they’re feeling like I’m 
more attentive. 
 
Finally, the fifth pharmacist noted that once patients became 
accustomed to being asked questions about quality of life (or 
possibly therapeutic alliance), that information was 
consequently provided up front. Such a change might suggest 
reduced time and clinical burden and allow for better clinical 
efficiency. 
P5: (about asking the questions in a routine 
manner)…but I think they’re more willing to provide 
me with the questions up front instead of me having 
to dig and dig and dig for it. So I think that’s the 
biggest I would say. 
 
Question 7: Most surprising 
Pharmacists were asked “what surprised you the most” about 
participating in the study. Again, there were varying 
responses, but mostly positive ones, ranging from practice 
change to acceptance of the innovation. One pharmacist 
noted a “wake-up call” and another noted the ease of 
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instrument administration. One also said that the study 
would inform the education of students. 
P1: What surprised me the most is what a wake-up 
call it was for me…and how much it changed the way 
I practice. That’s what surprised me… The most 
surprising thing was that it changed the way I 
practiced. 
P2: I think the main thing that surprised me the most 
was, again, the self-assessment on some of the 
patients that I was seeing…it definitely changed the 
way I um carry out my MTM sessions, and definitely 
it’s also a teaching tool for my students. 
P3: How easy it is to ask the questions! 
P4: That it was well-received for the most part. 
 
Discussion  
 In SMARTA, we defined our innovation as the administration 
of the ORS and SRS within the context of community 
pharmacy MTM services. While pharmacists may have, to 
some degree, previously incorporated elements of patient-
centered, outcome-informed care to their MTM practice, we 
are not aware of formalized systematic measurement of the 
particular outcomes advanced by the ORS and SRS, 
specifically measurement of therapeutic alliance within this 
clinical context. While our own lack of awareness should not 
be taken as an indication that such measurement does not 
exist, we are mostly confident that the formalized use of 
these scales in MTM practice could be described as an 
“innovative” practice. 
 
Adoption and maintenance of an innovation depends on a 
number of factors, including the relative advantage of the 
innovation over old ways of doing “business,” its 
compatability with existing values, experiences, and needs, its 
complexity (or, better said, simplicity), its trialability (the 
ability to experiment with the innovation for brief periods), 
and its observability (where the results of the innovation can 
be seen both individually in within a group or system).
11
 
 
First, we see that participating pharmacists perceived there 
to be advantages to using the ORS and SRS. The advantages 
included: 
 The (relatively) brief amount of clinical time it 
took to administer the scales. 
 The identification of otherwise unknown (or 
uninvestigated) medication therapy 
management issues. 
 The potential to positively impact medication 
adherence. 
 The development of trust, which pharmacists 
correlated with the likelihood of adherence. 
 The potential to positively impact quality of life. 
 Ease of asking questions. 
 
In these perceived advantages, we note overlap with other 
factors for adoption of an innovation, such as simplicity (in 
both ease of asking questions and relatively short amount of 
time to ask questions). Given that this was a time-limited 
study, we may also state that this innovative practice 
afforded participating pharmacists with the chance to 
experiment with the innovation (trialability). We also note 
that one pharmacist was particularly enthusiastic about this 
intervention. Such a pharmacist might be considered to be an 
“early adopter” or an “innovation champion.”
12
 Such 
champions often lead the further development of innovative 
practices throughout their respective professional 
communities. 
 
While there were perceived advantages, there are also 
perceived challenges to adoption. 
 Pharmacists received compensation for 
participating in the study but not afterwards. 
Pharmacists wanted to make sure the practice 
was worthwhile in terms of time and money. 
 Although the innovation was perceived as 
“easy” and “brief,” the perception of impact on 
time was still reported. 
 Some pharmacists doubted about the 
effectiveness to the intervention without 
evidence. 
 Some pharmacists had concerns about the use 
of the scales/the design of the scales with 
specific populations. 
 Some pharmacists had initial anxiety, specifically 
with regard to patient emotionality or other 
serious personal issues. There was a clear 
concern about having a lack of training to deal 
with emotional issues, as well as the potential 
time costs emotional issues may take. 
 
For some challenges, we believe that adoption of the 
innovative practice could be ameliorated through better 
training and education. Pharmacists received a one hour 
training prior to implementing the intervention, but it is likely 
that a more detailed training could reduce implementation 
anxiety. During training, we stressed, for example, that 
pharmacists were not expected to be “psychotherapists” but 
were encouraged to discuss any personal issues within the 
context of medication adherence. Furthermore, continued 
technical assistance and support would likely be beneficial to 
pharmacists should they implement this intervention in 
clinical practice. 
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For other challenges, there are larger systemic or institutional 
considerations, such as compensation for additional services. 
Finally, with the publication of the parent study, we hope that 
it provides pharmacists with at least preliminary evidence of 
the observability of the intervention and can begin to lay the 
foundation for future change in their pharmacy practice. 
 
Conclusion 
Pharmacists, in general, were receptive to participating in the 
original SMARTA study, which included the use of the ORS 
and SRS to measure patient outcomes and therapeutic 
alliance (with a distal goal of drawing correlation between the 
administration of these scales and medication adherence). 
Participation in the study encouraged pharmacists to reflect 
on their professional interactions with patients, and, for 
some, encouraged a shift in practice philosophy (i.e. take up a 
patient-centered stance). This shift was demonstrated by at 
least one pharmacist who noted the phrase, “They don’t care 
how much you know until they know how much you care.” 
Pharmacists had varying opinions on the degree to which 
their interactions could impact patient medication 
adherence, although they perceived other value and benefits 
secondary to the interactions, such as development of trust. 
While pharmacists did not maintain formal use of the scales 
after study end, they took away general principles of patient 
centered care and inquiry into aspects of life that may impact 
adherence.  
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